台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number221530

NCT Number(ClinicalTrials.gov Identfier)-

Active

2024-01-01 - 2030-06-30

Phase III

Recruiting4

ICD-10C76.0

Malignant neoplasm of head, face and neck

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9195.0

Malignant neoplasm of other and ill-defined sites of head, face and neck

-

Trial Applicant

GlaxoSmithKline
Sponsor

-
Trial scale

Multi-Regional Multi-Center
Update

2026/05/17

Investigators and Locations

Principal Investigator Ching Yun Hsieh 無

China Medical University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Shau-Hsuan Li 無

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 林進清無

CHANGHUA CHRISTIAN HOSPITAL

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator HUAI-CHENG HUANG

National Taiwan University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

Exclusion Criteria

The Estimated Number of Participants

Taiwan

25 participants
Global

864 participants